Ingelvac Provenza™ offers optimized intranasal administration of IAV-S vaccine

Intranasal administration stimulates mucosal immunity at the natural site of infection by influenza A virus in swine (IAV-S).1,2

Intranasal protection where IAV-S infection starts

Nozzle designed for optimized delivery.

Customized nozzle delivers vaccine as a mist appropriate for optimized delivery on respiratory mucosal surfaces.*

Prima® Mist nozzle

AVAILABLE IN A 50-DOSE PRESENTATION.

Ingelvac Provenza™ 50 dose presentation photo DIRECTIONS AND DOSAGE PRECAUTIONS

Intranasal vaccine administration

Administración de vacuna intranasal

AVAILABLE IN A 50-DOSE PRESENTATION.

Ingelvac Provenza™ 50 dose presentation photo DIRECTIONS AND DOSAGE PRECAUTIONS

* Complimentary Neogen® Prima® Mist nozzle must be listed by separate product code when ordering.

Neogen and Prima are registered trademarks of Neogen Corporation.

Disclaimer

WELCOME TO INGELVACPROVENZA.COM

Are you located within the United States of America?
ARE YOU A VETERINARIAN?

This is a required field

This website is an international information resource intended for veterinarians who are interested in information about Ingelvac Provenza™ and influenza A virus in swine.

While the Internet serves a global community, the pharmaceutical industry is subject to country-specific regulatory considerations. This means that the registration status and approved product label may not be the same in different countries.

INGELVAC PROVENZA™ IS ONLY CURRENTLY LICENCED IN THE UNITED STATES OF AMERICA. Information on this website is derived from the product label in the USA.

By checking the box below, you are declaring and confirming that you are a veterinarian professional and that you have read and understood this disclaimer.

You must accept the terms and conditions and data policy to enter the website

Ingelvac Provenza is a trademark of Boehringer Ingelheim Vetmedica GmbH. © 2018 Boehringer Ingelheim Vetmedica, Inc.